CRDL
NASDAQ
CA
Cardiol Therapeutics Inc. - Class A Common Shares
$1.41
▲ +$0.01
(+0.71%)
Vol 1.1M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$131.0M
ROE
-218.5%
D/E
1.40
Beta
1.92
52W
$1–$2
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 80.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.08 | $-0.07 | +$0.01 |
| Sep 2025 | $-0.09 | $-0.12 | $-0.03 |
| Jun 2025 | $-0.12 | $-0.10 | +$0.02 |
| Mar 2025 | $-0.14 | $-0.10 | +$0.04 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$12.7M | -$8.2M | -$8.3M | -$8.4M | -$10.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -232.7% | -210.2% | -210.2% | -232.7% | -218.5% | -218.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 1.21 | 0.86 | 0.86 | 1.21 | 1.40 | 1.40 |
| Current Ratio | 2.46 | 3.26 | 3.26 | 2.46 | 3.89 | 3.89 |
Key Ratios
ROA (TTM)
-154.3%
P/B
6.1
EPS (TTM)
$-0.42
CF/Share
$-0.43
52W High
$2.17
52W Low
$1.09
$1.09
52-Week Range
$2.17
Financial Health
Free Cash Flow
-$6.9M
Net Debt
-$11.5M
Cash
$11.6M
Total Debt
$134K
As of Sep 30, 2025
How does CRDL compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
CRDL valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
6.1
▲
189%
above
peers
(2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
CRDL profitability vs Pharmaceuticals peers
ROE
-218.5%
▼
303%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-154.3%
▼
312%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
CRDL financial health vs Pharmaceuticals peers
D/E ratio
1.4
▼
9%
below
peers
(1.5)
vs Peers
vs Industry
In line
Current ratio
3.9
▲
16%
above
peers
(3.4)
vs Peers
vs Industry
Below avg
Beta
1.9
▲
104%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
CRDL fundamentals radar
CRDL
Peer median
Industry
CRDL profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CRDL vs peers: key metrics
Latest News
No related news yet